Matt van de Rijn

Publication Details

  • Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors ONCOIMMUNOLOGY Edris, B., Willingham, S., Weiskopf, K., Volkmer, A. K., Volkmer, J., Muehlenberg, T., Weissman, I. L., van de Rijn, M. 2013; 2 (6)

    View details for DOI 10.4161/onci.24452

    View details for Web of Science ID 000322060900007

Stanford Medicine Resources:

Footer Links: